Longitudinal Evaluation of GTP1 as a PET Radioligand for Imaging Tau in the Brains of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers

Trial Profile

Longitudinal Evaluation of GTP1 as a PET Radioligand for Imaging Tau in the Brains of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2016

At a glance

  • Drugs Florbetapir F 18 (Primary)
  • Indications Alzheimer's disease
  • Focus Diagnostic use
  • Sponsors Genentech
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 Aug 2016 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
    • 02 Aug 2016 Planned primary completion date changed from 1 Nov 2017 to 1 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top